z-logo
Premium
Thrombophilia screening and thromboprophylaxis may benefit specific ethnic subgroups with paediatric acute lymphoblastic leukaemia
Author(s) -
BarzilaiBirenboim Shlomit,
AradCohen Nira,
Nirel Ronit,
Avrahami Galia,
Harlev Dan,
Gilad Gil,
Elhasid Ronit,
Izraeli Shai,
Litichever Naomi,
Elitzur Sarah
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15752
Subject(s) - medicine , thrombophilia , venous thromboembolism , factor v leiden , pediatrics , anticoagulant , thrombosis , venous thrombosis
Summary This study investigated the prevalence of inherited thrombophilia, risk of venous thromboembolism ( VTE ) and benefit of low molecular weight heparin prophylaxis in 476 Israeli children with acute lymphoblastic leukaemia ( ALL ) treated between 2004 and 2016. Thrombophilia was found in 15·5%. Arab children had a higher prevalence of F5 R506Q (factor V Leiden) than Jewish children (19·4% vs. 2·9%, P  <   0·01). Patients with thrombophilia had higher VTE rates VTE (26·5% vs. 5·6%, P  <   0·001). None of the thrombophilic children given prophylaxis had severe VTE . Routine evaluation for inherited thrombophilia followed by thromboprophylaxis when findings are positive may benefit at‐risk patients with ALL .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom